CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-03
DOI
10.3389/fonc.2020.00448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
- (2018) Anthony Tolcher et al. ONCOLOGIST
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
- (2018) Thomas Menter et al. Frontiers in Oncology
- miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
- (2018) Katerina Musilova et al. BLOOD
- MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells
- (2018) Katerina Cerna et al. LEUKEMIA
- Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
- (2018) Michäel Duruisseaux et al. Lancet Respiratory Medicine
- FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer
- (2018) Pushpamali De Silva et al. EBioMedicine
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- Combining multiple tools outperforms individual methods in gene set enrichment analyses
- (2016) Monther Alhamdoosh et al. BIOINFORMATICS
- The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells
- (2016) Martine van Keimpema et al. HAEMATOLOGICA
- N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
- (2016) P. J. Brown et al. HAEMATOLOGICA
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
- (2016) Alexander M. Lesokhin et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario
- (2016) Thais Bascuas et al. Journal of Translational Medicine
- The significance of FOXP1 in diffuse large B-cell lymphoma
- (2016) Duncan M. Gascoyne et al. LEUKEMIA & LYMPHOMA
- FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism
- (2016) T Sewastianik et al. ONCOGENE
- Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1
- (2016) Joseph D. Dekker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
- (2016) Douglas B. Johnson et al. Nature Communications
- The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells
- (2016) Martine van Keimpema et al. HAEMATOLOGICA
- N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
- (2016) P. J. Brown et al. HAEMATOLOGICA
- FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
- (2015) P J Brown et al. LEUKEMIA
- Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
- (2015) Rosalba Camicia et al. Molecular Cancer
- FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
- (2015) Matthew P. Walker et al. Science Signaling
- FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma
- (2015) Matthew P. Walker et al. Science Signaling
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
- (2015) Enrico Derenzini et al. Oncotarget
- FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF- B to promote survival of human B cells
- (2014) M. van Keimpema et al. BLOOD
- Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
- (2014) Laurie H. Sehn et al. BLOOD
- FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis
- (2013) R van Boxtel et al. CELL DEATH AND DIFFERENTIATION
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
- (2013) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- (2012) Davis J. McCarthy et al. NUCLEIC ACIDS RESEARCH
- Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma
- (2011) S. T. Wilkinson et al. BLOOD
- Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1
- (2011) V. J. Craig et al. BLOOD
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development
- (2009) X. Feng et al. BLOOD
- FOXP1 and BCL2 Show Similar Immunoenzymatic Pattern in Bone Marrow Trephines of Chronic Lymphocytic Leukemia Patients
- (2009) Petra Korać et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started